{"id":"fluoromethylcholine-18f","rwe":[],"tags":[{"label":"fluoromethylcholine (18F)","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"Active","category":"status"}],"phase":"phase_3","safety":{},"trials":[],"aliases":[],"patents":[],"pricing":[],"allNames":"[18f]-choline","offLabel":[],"synonyms":["fluoromethylcholine (18F)","[18F]-Choline"],"timeline":[],"approvals":[],"brandName":"[18F]-Choline","ecosystem":[],"mechanism":{"modality":"Small Molecule","drugClass":"fluoromethylcholine (18F)","explanation":"Imagine your body is a city, and cancer cells are like buildings that are being repaired. 18F-Choline is like a special dye that is taken up by the repair crews (cancer cells), making them visible to the imaging machine. This allows doctors to see where the cancer is and how it's growing.","oneSentence":"18F-Choline works by being taken up by cancer cells, where it is then visualized using positron emission tomography (PET) imaging.","technicalDetail":"18F-Choline is a positron-emitting radiopharmaceutical that is taken up by cells with high choline kinase activity, such as prostate cancer cells, through a process known as passive diffusion. Once inside the cells, it is phosphorylated to form 18F-fluoromethylphosphocholine, which is then trapped within the cells, allowing for visualization using PET imaging."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/4775","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://clinicaltrials.gov/search?intr=FLUOROMETHYLCHOLINE%20%2818F%29","fields":["trials"],"source":"ClinicalTrials.gov"},{"id":3,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=FLUOROMETHYLCHOLINE (18F)","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T11:32:40.869269","biosimilars":[],"competitors":[],"genericName":"fluoromethylcholine (18f)","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT07444723","phase":"PHASE2,PHASE3","title":"Accuracy of 18F-Fluorocholine PET/MR and NeuroEXPLORER PET/CT Imaging for Localization of Parathyroid Tumors","status":"NOT_YET_RECRUITING","sponsor":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","startDate":"2026-04-01","conditions":["Primary Hyperparathyroidism","Parathyroid Cancer","Multiple Endocrine Neoplasias","Heritable Hyperparathyroidism","Hyperparathyroid-jaw Tumor Syndrome"],"enrollment":193,"completionDate":"2036-02-05"},{"nctId":"NCT07218224","phase":"","title":"Expanded Access:18F-Fluorocholine for the Detection of Parathyroid Adenomas","status":"AVAILABLE","sponsor":"Thomas Hope","startDate":"","conditions":["Parathyroid Adenomas"],"enrollment":0,"completionDate":""},{"nctId":"NCT05891769","phase":"PHASE2,PHASE3","title":"99mTc Sestamibi SPECT/CT vs 18F Fluorocholine PET/CT","status":"RECRUITING","sponsor":"Andrei Iagaru","startDate":"2023-09-27","conditions":["Parathyroid Adenoma"],"enrollment":100,"completionDate":"2027-07-01"},{"nctId":"NCT07138820","phase":"NA","title":"18F-choline Positron-emission-tomography - Computed-tomography Compared to Conventional Imaging for Localizing Diseased Parathyroid Glands in Primary Hyperparathyroidism","status":"RECRUITING","sponsor":"Region Skane","startDate":"2023-01-01","conditions":["Primary Hyperparathyroidism"],"enrollment":88,"completionDate":"2027-02-28"},{"nctId":"NCT03891914","phase":"PHASE3","title":"Prospective Comparison of 18F-choline PET/CT and 18F-FDG PET/CT in the Initial Work-up of Multiple Myeloma","status":"COMPLETED","sponsor":"University Hospital, Bordeaux","startDate":"2019-11-12","conditions":["Myeloma Multiple"],"enrollment":20,"completionDate":"2023-01-31"},{"nctId":"NCT04965454","phase":"PHASE2","title":"Evaluation of Treatment Predictors Reflecting Beta-catenin Activation in Hepatocellular Carcinoma","status":"RECRUITING","sponsor":"Queen's Medical Center","startDate":"2022-03-28","conditions":["Hepatocellular Carcinoma Non-resectable"],"enrollment":80,"completionDate":"2028-06-30"},{"nctId":"NCT06835426","phase":"NA","title":"High-resolution PET-CT Specimen Imaging for the Perioperative Visualization of Resection Margins","status":"RECRUITING","sponsor":"Algemeen Ziekenhuis Maria Middelares","startDate":"2023-08-06","conditions":["Breast Carcinoma","Prostate Cancer Surgery","Thyroid Cancer","Parathyroid Adenomas","Skin Cancer","Genitourinary Cancer","Head and Neck Cancer","Hepatobiliary Cancers","Metabolic Abnormality","Neuro Endocrine Tumours","Brain Tumours","Gastro Intestinal Cancer","Thoracoscopic Surgery"],"enrollment":150,"completionDate":"2027-06-30"},{"nctId":"NCT06242119","phase":"","title":"Clinical Application of the J-PET Scanner Prototype","status":"RECRUITING","sponsor":"Jagiellonian University","startDate":"2024-03-07","conditions":["Prostate Cancer","Prostatic Hyperplasia","Prostatic Neoplasms","Prostate Cancer Metastatic","Neuroendocrine Tumors","Neuroendocrine Carcinoma"],"enrollment":25,"completionDate":"2025-10-30"},{"nctId":"NCT06334965","phase":"NA","title":"Multi-modal Characterisation of Hepatocellular Carcinoma (HCC) Treated With Targeted Radionuclide Therapy (TRT): Prospective Interventional Multicentre National Cohort","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2024-07-18","conditions":["Hepatocellular Carcinoma","Radioembolization"],"enrollment":180,"completionDate":"2029-09"},{"nctId":"NCT04895631","phase":"PHASE3","title":"18F-Fluorocholine Positron Emission Tomography (PET) for the Detection of Parathyroid Adenomas","status":"RECRUITING","sponsor":"Thomas Hope","startDate":"2021-06-30","conditions":["Hyperparathyroidism, Primary"],"enrollment":140,"completionDate":"2027-06-30"},{"nctId":"NCT05359939","phase":"NA","title":"A Head-to-head Comparison of MRI, CT, 18F-FDGal and 18F-choline in Patients With Hepatocellular Carcinoma","status":"RECRUITING","sponsor":"University of Aarhus","startDate":"2023-01-16","conditions":["Hepatocellular Carcinoma"],"enrollment":50,"completionDate":"2025-12"},{"nctId":"NCT04316845","phase":"NA","title":"18F-fluorocholine PET/CT for Hyperparathyroidism","status":"COMPLETED","sponsor":"Buddhist Tzu Chi General Hospital","startDate":"2018-01-16","conditions":["Hyperparathyroidism"],"enrollment":38,"completionDate":"2019-12-31"},{"nctId":"NCT05622162","phase":"PHASE3","title":"Prospective Comparative Study for Patients With Biochemical Recurrence Prostate Cancer Detecting by 18F-JK-PSMA-7","status":"ACTIVE_NOT_RECRUITING","sponsor":"ITEL Telecomunicazioni Srl","startDate":"2022-12-19","conditions":["Prostate Cancer","18F- Fluorocholine","PSMA PET","Radiotherapy","Prostatectomy","Tumor of Prostate"],"enrollment":106,"completionDate":"2024-06"},{"nctId":"NCT04150458","phase":"PHASE3","title":"Fluorocholine PET/CT Basket Trial","status":"ENROLLING_BY_INVITATION","sponsor":"Sir Mortimer B. Davis - Jewish General Hospital","startDate":"2022-11-30","conditions":["Fluorocholine PET/CT"],"enrollment":2000,"completionDate":"2030-07"},{"nctId":"NCT04009174","phase":"NA","title":"Multi-modality Prostate Cancer Image Guided Interventions","status":"COMPLETED","sponsor":"London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's","startDate":"2012-02-12","conditions":["Prostate Cancer"],"enrollment":52,"completionDate":"2023-06-21"},{"nctId":"NCT03324893","phase":"NA","title":"FCH PET/MRI Parathyroid Localization","status":"COMPLETED","sponsor":"University Health Network, Toronto","startDate":"2018-04-03","conditions":["18F-fluorocholine","Positron-Emission Tomography","Hyperparathyroidism, Primary"],"enrollment":47,"completionDate":"2021-06-23"},{"nctId":"NCT04391348","phase":"NA","title":"Combination PET With 18F-fluorodeoxyglucose (18F-FDG) and 18 F-choline in Patient With HCC","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2020-07-17","conditions":["Hepatocellular Carcinoma"],"enrollment":230,"completionDate":"2023-04-28"},{"nctId":"NCT02640313","phase":"PHASE3","title":"Molecular Imaging of Plaque Vulnerability","status":"UNKNOWN","sponsor":"Maastricht University Medical Center","startDate":"2015-12","conditions":["Plaque, Atherosclerotic"],"enrollment":14,"completionDate":"2024-03-01"},{"nctId":"NCT04349358","phase":"NA","title":"FCH vs FDG PET/CT in Detection of Lesions in Patients With Multiple Myeloma (MIM)","status":"RECRUITING","sponsor":"Centre Georges Francois Leclerc","startDate":"2020-12-15","conditions":["Multiple Myeloma"],"enrollment":38,"completionDate":"2030-12-15"},{"nctId":"NCT02847468","phase":"NA","title":"Multimetabolic 18F-Fluorodeoxyglucose (FDG) and 18F-Fluorocholine (FCH) Positron Emission Tomography (PET) as an Early Predictive Factor of Overall Survival in Patients With Advanced Hepatocellular Carcinoma Treated With Sorafenib","status":"TERMINATED","sponsor":"Centre Georges Francois Leclerc","startDate":"2017-03-27","conditions":["Carcinoma, Hepatocellular"],"enrollment":61,"completionDate":"2021-12-23"},{"nctId":"NCT02037945","phase":"NA","title":"18F-Fluorocholine (18F-FCho) to Distinguish Necrosis From Recurrence in Brain Metastases","status":"COMPLETED","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2014-01","conditions":["Brain Metastases"],"enrollment":19,"completionDate":"2022-12-08"},{"nctId":"NCT01310192","phase":"PHASE1","title":"Cancer Localization in the Prostate With F-18 Fluorocholine Positron Emission Tomography","status":"COMPLETED","sponsor":"Queen's Medical Center","startDate":"2004-06","conditions":["Prostate Cancer"],"enrollment":20,"completionDate":"2008-07"},{"nctId":"NCT02815033","phase":"PHASE2","title":"Imaging Staging and Response Prediction in Metastatic Hormono-Sensitive Prostate Cancer Patients Receiving Enzalutamide","status":"COMPLETED","sponsor":"The European Uro-Oncology Group","startDate":"2015-07","conditions":["Prostate Cancer Metastatic"],"enrollment":66,"completionDate":"2020-12"},{"nctId":"NCT02131649","phase":"NA","title":"PET/MRI for Men Being Considered for Radiotherapy for Suspected Prostate Cancer Recurrence Post-Prostatectomy","status":"COMPLETED","sponsor":"London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's","startDate":"2015-02","conditions":["Prostate Cancer"],"enrollment":99,"completionDate":"2021-01"},{"nctId":"NCT03764007","phase":"PHASE2,PHASE3","title":"18F-Fluorocholine for the Detection of Parathyroid Adenomas","status":"COMPLETED","sponsor":"Thomas Hope","startDate":"2016-09-21","conditions":["Hyperparathyroidism, Primary"],"enrollment":98,"completionDate":"2021-05-31"},{"nctId":"NCT02397408","phase":"PHASE2","title":"11C- and 18F-Choline PET/MR Imaging for Prostate Cancer","status":"COMPLETED","sponsor":"University of California, San Francisco","startDate":"2015-04-09","conditions":["Prostate Cancer"],"enrollment":18,"completionDate":"2015-06-30"},{"nctId":"NCT04626206","phase":"","title":"Multi -paramEtric Imaging to Assess Treatment REsponse After Stereotactic Radiosurgery of Brain Metastases","status":"UNKNOWN","sponsor":"Royal Marsden NHS Foundation Trust","startDate":"2020-12","conditions":["Brain Metastases, Adult"],"enrollment":12,"completionDate":"2021-08"},{"nctId":"NCT03643055","phase":"","title":"18F-Fluorocholine PET/CT in Medullary Thyroid Cancer","status":"UNKNOWN","sponsor":"University Medical Centre Ljubljana","startDate":"2014-09-03","conditions":["Medullary Thyroid Cancer"],"enrollment":80,"completionDate":"2024-09-03"},{"nctId":"NCT04570033","phase":"NA","title":"The Utility of 18F-fluorocholine PET/CT in the Imaging of Parathyroid Adenomas","status":"COMPLETED","sponsor":"Military Institute od Medicine National Research Institute","startDate":"2016-01-01","conditions":["Hyperparathyroidism","Parathyroid Adenoma"],"enrollment":65,"completionDate":"2020-01-01"},{"nctId":"NCT04340765","phase":"NA","title":"18F-fluorocholine and 18F-fluoride PET in Prostate Cancer","status":"COMPLETED","sponsor":"Buddhist Tzu Chi General Hospital","startDate":"2018-02-01","conditions":["Prostate Cancer","Fluorocholine"],"enrollment":36,"completionDate":"2019-12-31"},{"nctId":"NCT03252990","phase":"","title":"18F-fluorocholine PET-MR Imaging of Coronary Plaque Vulnerability","status":"COMPLETED","sponsor":"Maastricht University Medical Center","startDate":"2018-03-02","conditions":["Myocardial Infarction","Myocardial Ischemia","Atherosclerosis","Coronary Artery Disease","Coronary Stenosis","Heart Attack","Multi Vessel Coronary Artery Disease"],"enrollment":15,"completionDate":"2019-12-06"},{"nctId":"NCT01751737","phase":"NA","title":"Choline PET/CT and MRI for Targeted Prostate Biopsy","status":"COMPLETED","sponsor":"University of Michigan","startDate":"2012-11","conditions":["Prostate Cancer"],"enrollment":63,"completionDate":"2017-06"},{"nctId":"NCT03555487","phase":"PHASE3","title":"Clinical Value of 18F-FCH PET in Localizing Parathyroid Lesions: Comparison With MIBI Scan.","status":"COMPLETED","sponsor":"National Taiwan University Hospital","startDate":"2015-05-05","conditions":["Parathyroid Diseases"],"enrollment":103,"completionDate":"2018-10-01"},{"nctId":"NCT02121600","phase":"NA","title":"18F-FCH PET/MRI to Assess Tumor Response in Castration Resistant Prostate Cancer","status":"TERMINATED","sponsor":"London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's","startDate":"2014-09","conditions":["Prostate Cancer"],"enrollment":5,"completionDate":"2018-03"},{"nctId":"NCT02784223","phase":"NA","title":"Diagnostic Value of 18F-Choline PET/CT in Patients With a Thyroid Nodule With an Indeterminate Cytology: Pilot Study","status":"COMPLETED","sponsor":"Centre Francois Baclesse","startDate":"2016-05","conditions":["Thyroid Gland"],"enrollment":107,"completionDate":"2019-03-28"},{"nctId":"NCT01395030","phase":"PHASE2","title":"PET/CT in Diagnosing Patients With Liver Cancer Undergoing Surgical Resection","status":"COMPLETED","sponsor":"Queen's Medical Center","startDate":"2011-08-15","conditions":["Adult Hepatocellular Carcinoma","Localized Resectable Adult Liver Carcinoma"],"enrollment":64,"completionDate":"2018-05-31"},{"nctId":"NCT02608619","phase":"","title":"Uptake and Biodistribution of 18F-fluorocholine in Histiocytic Disorders by PET Imaging and Biopsy Measurement","status":"COMPLETED","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2015-11","conditions":["Erdheim-Chester Disease","Langerhans Cell Histiocytosis","Histiocytic Disorders"],"enrollment":3,"completionDate":"2018-08"},{"nctId":"NCT03376360","phase":"","title":"Functional Medical Imaging Quantization in Prostate Cancer","status":"COMPLETED","sponsor":"University Hospital, Brest","startDate":"2015-10-01","conditions":["Prostate Cancer"],"enrollment":61,"completionDate":"2017-05-01"},{"nctId":"NCT02840552","phase":"PHASE3","title":"The Safety and Efficacy of 18F-Fluoromethylcholine (18F-FCH) PET/CT in Prostate Cancer","status":"COMPLETED","sponsor":"Sir Mortimer B. Davis - Jewish General Hospital","startDate":"2016-09","conditions":["Prostate Cancer"],"enrollment":60,"completionDate":"2018-03"},{"nctId":"NCT03623425","phase":"PHASE3","title":"Comparison of PET With 68GA-PSMA-11 and 18F-Fluorocholine for Recurrence in Men With Prostate Cancer","status":"UNKNOWN","sponsor":"Central Hospital, Nancy, France","startDate":"2019-02-01","conditions":["Prostate Cancer"],"enrollment":46,"completionDate":"2020-05-01"},{"nctId":"NCT01804231","phase":"NA","title":"Prospective Study Using Hybrid PET/MRI to Evaluate Men With Suspected Recurrence Following Treatment for Prostate Cancer","status":"COMPLETED","sponsor":"London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's","startDate":"2013-07-09","conditions":["Prostate Cancer"],"enrollment":22,"completionDate":"2016-10-12"},{"nctId":"NCT00628940","phase":"PHASE1","title":"PET Imaging of High-grade Glioma Using 18F-fluoromethylcholine: a Tool for the Early Detection of Tumour Recurrence After Combined Radiochemotherapy?","status":"COMPLETED","sponsor":"University Ghent","startDate":"2010-01-12","conditions":["High-grade Glioma of the Brain"],"enrollment":90,"completionDate":"2018-03-22"},{"nctId":"NCT03344822","phase":"PHASE2,PHASE3","title":"Place of 68Ga-PSMA-11 PET-CT in the Therapeutic Decision at the End of the Initial Staging for High Risk Prostate Cancer Patients","status":"UNKNOWN","sponsor":"Central Hospital, Nancy, France","startDate":"2018-01-02","conditions":["Prostate Cancer"],"enrollment":33,"completionDate":"2019-12-31"},{"nctId":"NCT00928252","phase":"PHASE1,PHASE2","title":"Chemotherapy Response Monitoring With 18F-choline PET/CT in Hormone Refractory Prostate Cancer","status":"COMPLETED","sponsor":"Queen's Medical Center","startDate":"2009-06","conditions":["Hormone Refractory Prostate Cancer"],"enrollment":25,"completionDate":"2016-06"},{"nctId":"NCT03203668","phase":"NA","title":"18F-fluorocholine PET/CT Imaging in Hyperparathyroidism","status":"UNKNOWN","sponsor":"University Medical Centre Ljubljana","startDate":"2013-01-01","conditions":["Hyperparathyroidism"],"enrollment":1000,"completionDate":"2020-12-31"},{"nctId":"NCT02793882","phase":"","title":"Correlation Between SUV on 18F-Fluorocholine PET/CT and Gleason Score in Prostate Cancer","status":"COMPLETED","sponsor":"Sir Mortimer B. Davis - Jewish General Hospital","startDate":"2013-09","conditions":["Prostate Cancer"],"enrollment":218,"completionDate":"2017-04-24"},{"nctId":"NCT01993160","phase":"NA","title":"18F-FCH (Fluorocholine)-PET/MR in Staging of High-Risk Prostate Cancer","status":"COMPLETED","sponsor":"University Health Network, Toronto","startDate":"2013-12","conditions":["Prostate Cancer"],"enrollment":50,"completionDate":"2016-12"},{"nctId":"NCT02232685","phase":"NA","title":"Whole Body Bone Scan vs 18F-Choline PET/CT in Prostate Cancer","status":"COMPLETED","sponsor":"Odense University Hospital","startDate":"2014-09","conditions":["Prostate Cancer"],"enrollment":143,"completionDate":"2016-07"},{"nctId":"NCT02151097","phase":"","title":"PRIME - PRostate Imaging for Margin Evaluation","status":"COMPLETED","sponsor":"Lightpoint Medical Limited","startDate":"2014-11","conditions":["Prostatic Neoplasms"],"enrollment":7,"completionDate":"2016-06"},{"nctId":"NCT01956409","phase":"PHASE4","title":"Proton MR Spectroscopy and 18F-Fluorocholine PET for Breast Cancer Diagnosis","status":"UNKNOWN","sponsor":"National Taiwan University Hospital","startDate":"2012-09","conditions":["Breast Cancer Diagnosis","Positron Emission Tomography","Magnetic Resonance Imaging"],"enrollment":80,"completionDate":"2017-03"},{"nctId":"NCT01501630","phase":"","title":"Role of PET/CT With Fluorine-18 Tracers of Bone Metastases in Prostate Cancer","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2011-12","conditions":["Prostate Cancer"],"enrollment":112,"completionDate":"2014-12"},{"nctId":"NCT02074202","phase":"PHASE3","title":"To Evaluate the Efficacy and Safety of (18F-FCH) Comparing With (18F-FDG) for Detecting Hepatocellular Carcinoma","status":"UNKNOWN","sponsor":"National Taiwan University Hospital","startDate":"2014-02","conditions":["Hepatocellular Carcinoma","Liver Disease"],"enrollment":150,"completionDate":"2015-03"},{"nctId":"NCT00670527","phase":"NA","title":"[18F] Fluorocholine FCH Positron Emission Tomography (PET)/Computed Tomography (CT) for Detection of Prostate Cancer Lymph Nodes Metastases","status":"UNKNOWN","sponsor":"Odense University Hospital","startDate":"2008-01","conditions":["Prostate Cancer"],"enrollment":205,"completionDate":"2013-04"},{"nctId":"NCT01132599","phase":"PHASE2","title":"Comparing PET-CT Using C-11 Choline and 18F-Fluoromethylcholine in Patients With Metastatic Prostate Cancer","status":"WITHDRAWN","sponsor":"Cancer Research UK","startDate":"2010-05","conditions":["Prostate Cancer"],"enrollment":0,"completionDate":""},{"nctId":"NCT01089881","phase":"","title":"The Effectiveness of 18F-fluorocholine Positron Emission Tomography (PET) in Detecting, Staging and Following-up Prostate Cancer","status":"UNKNOWN","sponsor":"National Taiwan University Hospital","startDate":"2008-01","conditions":["Prostate Cancer"],"enrollment":150,"completionDate":"2010-12"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"UNII":"700YTQ6F2B","CHEBI":"CHEBI:136031","UMLSCUI":"C1744278","ChEMBL_ID":"CHEMBL3707345","PUBCHEM_CID":"449673"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":0,"therapeuticAreas":["Oncology"],"biosimilarFilings":[],"recentPublications":[],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"","companyId":"","modality":"Small molecule","firstApprovalDate":"","aiSummary":"18F-Choline, also known as Fluoromethylcholine (18F), is a small molecule radiopharmaceutical developed for diagnostic imaging purposes. Its exact target is unknown, but it is used to visualize certain types of cancer, particularly prostate cancer. The commercial status of 18F-Choline is unclear, and it is not approved by the FDA for any indications. Further research is needed to determine its safety and efficacy. As a radiopharmaceutical, it is not intended for therapeutic use.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":true,"score":2}}